NO20050396L - Adjuvant viral partikkel - Google Patents

Adjuvant viral partikkel

Info

Publication number
NO20050396L
NO20050396L NO20050396A NO20050396A NO20050396L NO 20050396 L NO20050396 L NO 20050396L NO 20050396 A NO20050396 A NO 20050396A NO 20050396 A NO20050396 A NO 20050396A NO 20050396 L NO20050396 L NO 20050396L
Authority
NO
Norway
Prior art keywords
vlp
protein
viral particle
virus
immunogen
Prior art date
Application number
NO20050396A
Other languages
English (en)
Norwegian (no)
Inventor
Denis Leclerc
Philippe Tessier
Constantio Iii Ro Lopez-Macias
Nathalie Majeau
Original Assignee
Denis Leclerc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denis Leclerc filed Critical Denis Leclerc
Publication of NO20050396L publication Critical patent/NO20050396L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6075—Viral proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/26011—Flexiviridae
    • C12N2770/26023—Virus like particles [VLP]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
NO20050396A 2002-07-05 2005-01-25 Adjuvant viral partikkel NO20050396L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39365902P 2002-07-05 2002-07-05
PCT/CA2003/000985 WO2004004761A2 (fr) 2002-07-05 2003-06-30 Particule virale d'adjuvant

Publications (1)

Publication Number Publication Date
NO20050396L true NO20050396L (no) 2005-01-25

Family

ID=30115621

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050396A NO20050396L (no) 2002-07-05 2005-01-25 Adjuvant viral partikkel

Country Status (15)

Country Link
US (2) US7641896B2 (fr)
EP (2) EP2272525A3 (fr)
JP (1) JP4953570B2 (fr)
KR (1) KR20050044886A (fr)
CN (1) CN1665528B (fr)
AU (1) AU2003281246A1 (fr)
BR (1) BR0312474A (fr)
CA (1) CA2434000C (fr)
DK (1) DK1523329T3 (fr)
ES (1) ES2431963T3 (fr)
HK (1) HK1075214A1 (fr)
MX (1) MXPA05000287A (fr)
NO (1) NO20050396L (fr)
PT (1) PT1523329E (fr)
WO (1) WO2004004761A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101189B2 (en) 2002-07-05 2012-01-24 Folia Biotech Inc. Vaccines and immunopotentiating compositions and methods for making and using them
DK1523329T3 (da) * 2002-07-05 2013-10-14 Folia Biotech Inc Viruspartikeladjuvant
WO2006032674A1 (fr) * 2004-09-21 2006-03-30 Cytos Biotechnology Ag Particules ressemblant à un virus comprenant une protéine de fusion de la protéine de coque de ap205 et d'un polypeptide antigénique
BRPI0516775A (pt) 2004-10-25 2008-09-23 Cytos Biotechnology Ag ensaios de polipeptìdeo de antìgeno de inibidor gástrico (gip) e seus usos
KR100688522B1 (ko) * 2005-01-18 2007-03-02 삼성전자주식회사 영상데이터 압축기 및 압축방법
BRPI0611336A2 (pt) * 2005-06-01 2010-08-31 Dow Global Technologies Inc método para produzir uma partìcula multivalente semelhante a vìrus, partìcula multivalente semelhante a vìrus, método de aumentar a solubilidade de uma partìcula multivalente semelhante a vìrus e vacina
AT503690A1 (de) 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
WO2012048430A1 (fr) * 2010-10-14 2012-04-19 Folia Biotech Inc. Nucléoprotéine-particule de type virus de la mosaïque de papaye conjugués par affinité
CA2669485C (fr) * 2006-11-15 2017-01-03 Folia Biotech Inc. Vaccins contre la grippe a base du virus de la mosaique du papayer
EP2078086A4 (fr) 2006-11-15 2010-06-30 Folia Biotech Inc Systèmes d'antigène conjugué par affinité immunogène fondés sur le virus de la mosaïque de la papaye et utilisation de ceux-ci
MX2009007942A (es) * 2007-01-26 2010-06-01 Folia Biotech Inc Vacunas basadas en virus del mosaico de la papaya contra salmonella typhi y otros patogenos enterobacterianos.
US20090093019A1 (en) * 2007-04-27 2009-04-09 Phelps Jamie P Production and in vivo assembly of soluble recombinant icosahedral virus-like particles
JP2010538619A (ja) * 2007-09-11 2010-12-16 ユニベルシテ ラヴァル Ｍａｌｖａモザイクウイルスおよびウイルス様粒子およびこれらの使用
WO2010003219A1 (fr) * 2008-06-17 2010-01-14 Universite Laval Compositions contenant des porines de salmonelle et leurs utilisations comme adjuvants et vaccins
US20110206727A1 (en) * 2008-07-30 2011-08-25 Denis Leclerc Multivalent Vaccines Based on Papaya Mosaic Virus and Uses Thereof
WO2012078069A1 (fr) 2010-12-09 2012-06-14 Iosif Grigorievich Atabekov Nano- et microparticules sphériques dérivées de virus de plante pour la présentation de protéines ou d'épitopes étrangères
EP2707480B1 (fr) 2011-05-13 2017-08-02 Folia Biotech Inc. Particules pseudo-virales (vlp)et leur procédé de préparation
TR201905619T4 (tr) 2011-06-09 2019-05-21 Biomay Ag Alerji aşısı olarak peptit taşıyıcı füzyon proteinleri.
US20150056231A1 (en) * 2012-04-02 2015-02-26 Folia Biotech Inc. Recombinant papaya mosaic virus coat proteins and uses thereof in influenza vaccines
CA2924819A1 (fr) * 2013-09-19 2015-03-26 Folia Biotech Inc. Virus de la mosaique de la papaye et pseudo-particules virales dans la therapie du cancer
US20180153984A1 (en) * 2015-04-30 2018-06-07 The Regents Of The University Of California Adjuvant particles comprising adenosine receptor antagonists
CA3208643A1 (fr) 2021-01-18 2022-07-21 Conserv Bioscience Limited Compositions immunogenes de coronavirus, methodes et utilisations de celles-ci

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79880A0 (en) 1985-08-29 1986-11-30 Inst Medical W & E Hall Recombinant virus
US5977438A (en) 1988-02-26 1999-11-02 Biosource Technologies, Inc. Production of peptides in plants as viral coat protein fusions
DE4006630A1 (de) 1990-03-03 1991-09-12 Behringwerke Ag Humane monoklonale antikoerper gegen tollwutviren, ihre herstellung und verwendung
CA2089497A1 (fr) 1990-08-15 1992-02-16 Lendon Payne Particules virales hybrides a replication defectueuse
US5443969A (en) * 1992-10-29 1995-08-22 Rutgers University RNA packaging system
GB9414118D0 (en) 1994-07-13 1994-08-31 Axis Genetics Ltd Modified plant viruses as vectors of heterologous peptides
NZ294014A (en) 1994-10-18 1999-02-25 Scottish Crop Research Inst A method of producing a rod-shaped or pseudovirus capable of replicating and assembling in plants
GB9607899D0 (en) 1996-04-17 1996-06-19 Scottish Crop Research Inst Virus-like particle
US6042832A (en) 1996-08-28 2000-03-28 Thomas Jefferson University Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins
WO1998050071A1 (fr) * 1997-05-01 1998-11-12 Chiron Corporation Utilisation de particules de type viral en tant qu'adjuvants
US6228368B1 (en) 1997-10-06 2001-05-08 Loyola University Of Chicago Papilloma virus capsomere formulations and method of use
DE19752855C2 (de) 1997-11-28 2003-04-03 Bundesrepublik Deutschland Let Retrovirale Pseudotyp-Vektoren mit modifizierten Oberflächen-Hüllproteinen und Verpackungszelle zu ihrer Herstellung für den selektiven Gentransfer
GB9806666D0 (en) 1998-03-27 1998-05-27 Stanley Margaret Antigen preparation and use
EP1100890A2 (fr) 1998-07-27 2001-05-23 Genentech, Inc. Efficacite de transformation amelioree de l'expression a la surface des phages par modification d'une proteine de coque
FR2786773B1 (fr) 1998-12-03 2002-03-08 Univ Paris Curie Proteines d'enveloppe, methodes et utilisations
KR100715954B1 (ko) 1998-12-04 2007-05-09 바이오겐 아이덱 엠에이 인코포레이티드 펩티드 리간드에 의하여 부착된 다중 면역원성 성분을보유한 ｈｂｖ 코어 항원 입자
DE19904800C1 (de) 1999-02-05 2001-02-08 Eberhard Hildt Partikel zur Gentherapie
GB9921337D0 (en) * 1999-09-09 1999-11-10 Axis Genetics Plc Modified plant viruses
GB9924352D0 (en) 1999-10-14 1999-12-15 Hellendoorn Koen Methods,compositions and applications relating to the generation of novel plant viral particles
GB9924351D0 (en) * 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
US6730306B1 (en) 2000-03-08 2004-05-04 Large Scale Biology Corporation Parvovirus vaccine as viral coat protein fusions
AUPQ661600A0 (en) 2000-03-31 2000-05-04 Macfarlane Burnet Centre For Medical Research Limited, The A nucleic acid construct and methods related thereto
IT1317046B1 (it) 2000-06-16 2003-05-26 Ist Superiore Sanita Proteina di fusione, particelle virali chimeriche che la espongono sulcapside, piante infettate con tali particelle, loro usi e composizioni
WO2002000169A2 (fr) 2000-06-26 2002-01-03 The United States Of America, As Represented By The Secretary Of Agriculture Production de vaccins par utilisation de plantes transgeniques ou de virus de plantes modifies comme vecteurs d'expression et proteines de coque virales transencapsidees utilisees comme systemes de presentation d'epitopes
AU2001275438A1 (en) 2000-07-06 2002-01-21 Georgetown University Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof
GB0028319D0 (en) * 2000-11-20 2001-01-03 Univ Southampton Materials and methods relating to fusion proteins for inducing an immune response
ITRM20010332A1 (it) * 2001-06-11 2002-12-11 Ist Superiore Sanita Vaccini a subunita' e procedimenti per la loro produzione.
US8101189B2 (en) 2002-07-05 2012-01-24 Folia Biotech Inc. Vaccines and immunopotentiating compositions and methods for making and using them
DK1523329T3 (da) * 2002-07-05 2013-10-14 Folia Biotech Inc Viruspartikeladjuvant

Also Published As

Publication number Publication date
BR0312474A (pt) 2005-04-26
CN1665528B (zh) 2013-05-15
AU2003281246A1 (en) 2004-01-23
ES2431963T3 (es) 2013-11-28
EP1523329A2 (fr) 2005-04-20
CA2434000C (fr) 2012-07-17
PT1523329E (pt) 2013-10-08
EP2272525A3 (fr) 2011-11-16
HK1075214A1 (en) 2005-12-09
JP2006504644A (ja) 2006-02-09
US7641896B2 (en) 2010-01-05
CN1665528A (zh) 2005-09-07
JP4953570B2 (ja) 2012-06-13
WO2004004761A3 (fr) 2004-05-06
KR20050044886A (ko) 2005-05-13
CA2434000A1 (fr) 2004-01-05
EP2272525A2 (fr) 2011-01-12
EP1523329B1 (fr) 2013-07-24
DK1523329T3 (da) 2013-10-14
US20090280145A1 (en) 2009-11-12
US8282940B2 (en) 2012-10-09
US20050048082A1 (en) 2005-03-03
WO2004004761A2 (fr) 2004-01-15
MXPA05000287A (es) 2005-09-08

Similar Documents

Publication Publication Date Title
NO20050396L (no) Adjuvant viral partikkel
DK1450856T3 (da) Pakning af immunstimulatorisk CpG i virus-lignende partilker, fremgangsmåde og anvendelse
NO20056074L (no) Hoy titer rekombinante influensavira til vaksiner og genterapi
EA200801756A1 (ru) Противогриппозные вакцины, содержащие гемагглютинин и белки матрикса
WO2008014521A3 (fr) Vaccins améliorés et leurs procédés d'utilisation
WO2006086188A3 (fr) Utilisation de sequences consensus en tant qu'antigene de vaccin dans le but d'ameliorer la reconnaissance de variants viraux virulents
DK1294893T3 (da) Modifikation af hepatitis B-kerneantigen
CY1110359T1 (el) Εμβολια με βαση σιρκοϊους χοιρων
IL164812A0 (en) Packaged virus-like particles for use as adjuvants: method of preparation and use
AR041880A1 (es) Composicion inmunogena
SG156652A1 (en) Yeast-based therapeutic for chronic hepatitis c infection
WO2011054011A3 (fr) Protéines consensus du virus de la fièvre aphteuse (fmdv), séquences codant pour celles-ci et vaccins obtenus de celles-ci
ECSP045300A (es) Antígenos virales
DK1292328T3 (da) Kimære humant papillomvirus- (HPV) - molekyler og deres anvendelse
WO2002072036A3 (fr) Procedes et compositions comprenant des polypeptides du virus west nile
EP2290091A3 (fr) Virus de la rougeole recombinants exprimant des epitopes d' antigenes de virus à ARN et utilisation des virus recombinants pour la preparation de vaccins
ATE267256T1 (de) Hepatis e-virus antigene und dessen verwendungen
WO2006024240A3 (fr) Composition vaccinale contre le virus de l'hepatite c
BR0112020A (pt) Partìculas tipo vìrus de bvdv
DK1334197T3 (da) Gær-afledt vaccine mod IPNV
EE200200157A (et) Vaktsiin
EP1439856A4 (fr) Vaccin antirabique recombine, preparation et utilisation de ce vaccin
DE69922212D1 (de) Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)
AR041515A1 (es) Vacuna a dna contra el virus de papiloma humano
DE60330795D1 (de) Impfstoff gegen west nile virus

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application